document.write('

NYT > Biotechnology

Sanofi Makes Public a $18.5 Billion Bid for Genzyme
The French drug maker Sanofi-Aventis disclosed its $18.5 billion bid for the American biotechnology firm Genzyme.

Stryker and Massachusetts Settle Over Marketing Practices
Martha Coakley, the Massachusetts attorney general, said Stryker “promoted uses of its products that were not shown to be safe ...

');